Patent details

Basic Information

Publication number:

EP1864666

PCT Application Number:

PCT/JP/2006/306826

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP067307744

PCT Publication Number:

WO/2006/106915

First applicant's nationality:

Translation Language:

EPO Publication Language:

Not available

English Title of Invention:

PROTECTIVE AGENT FOR RETINAL NEURONAL CELL CONTAINING PROSTAGLANDIN F2 ALPHA DERIVATIVE AS ACTIVE INGREDIENT

French Title of Invention:

AGENT PROTECTEUR POUR LA CELLULE NEURONALE RETINIENNE CONTENANT UN DERIVE DE PROSTAGLANDINE F2 ALPHA COMME INGREDIENT ACTIF

German Title of Invention:

SCHUTZMITTEL FÜR EINE RETINALE NERVENZELLE MIT EINEM PROSTAGLANDIN-F2-ALPHA-DERIVAT ALS WIRKSTOFF

SPC Number:

Dates

Filing date:

31/03/2006

Grant date:

15/08/2012

EP Publication Date:

15/08/2012

PCT Publication Date:

12/10/2006

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

12/12/2007

EP B1 Publication Date:

15/08/2012

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

31/03/2019

Expiration date:

31/03/2026

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

02/10/2018

 

 

Name:

AGC Inc.

Address:

5-1, Marunouchi 1-chome, Chiyoda-ku, Tokyo 100-8405, Japan (JP)

Name:

SANTEN PHARMACEUTICAL CO. LTD.

Address:

9-19, Shimoshinjo 3-chome, Higashiyodogawa-ku, Osaka-shi, Osaka 533, Japan (JP)

History of Owners

From:

31/03/2006

To:

02/10/2018

Name:

Asahi Glass Company Limited

Address:

Shin-Marunouchi Building 1-5-1 Marunouchi, Chiyoda-ku Tokyo 100-8405, Japan (JP)

Name:

SANTEN PHARMACEUTICAL CO. LTD.

Address:

9-19, Shimoshinjo 3-chome, Higashiyodogawa-ku, Osaka-shi, Osaka 533, Japan (JP)

Agent

Name:

OFFICE FREYLINGER S.A.

From:

23/08/2012

Address:

Boîte Postale 48, L-8001, STRASSEN, Luxembourg (LU)

To:

Inventor

1

Name:

SHIMAZAKI Atsushi, SANTEN PHARMACEUTICAL CO., LTD

Address:

Japan (JP)

2

Name:

ISHIDA Naruhiro, SANTEN PHARMACEUTICAL CO., LTD

Address:

Japan (JP)

Priority

Priority Number:

2005100348

Priority Date:

31/03/2005

Priority Country:

Japan (JP)

Classification

Main IPC Class:

A61K 31/5575;

Publication

Bulletin

Bulletin Heading:

CO

Bulletin edition number:

2018/12

Publication date:

15/11/2018

Description:

Section M : Transfers of property (Art. 53 of the law), change of name and/or address

Deed

Change of owner(s)

Change Kind/ Decision Type:

Change of owner(s) name/address

Deed Number:

RC20180000320A

Date Registered:

02/10/2018

Licence Effective Date:

Licence Expiration Date:

Scope of Licence:

Deed Filer:

MARKS & CLERK LLP

Journal Edition Number:

Text:

Country Code:

Updated Licence Number:

Terminated Licence Number:

Added Owner(s)

1

Name:

SANTEN PHARMACEUTICAL CO. LTD.

Address:

9-19, Shimoshinjo 3-chome, Higashiyodogawa-ku, Osaka-shi, Osaka 533, Japan (JP)

2

Name:

AGC Inc.

Address:

5-1, Marunouchi 1-chome, Chiyoda-ku, Tokyo 100-8405, Japan (JP)

Removed Pledgee

Name:

Address:

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

08/03/2018

Last Annual Fee Paid Number:

13

Last Annual Fee Paid Amount:

180 Euro

Payer:

MARKS & CLERK LLP

Filing date	Document type	Number of pages
02/10/2018	Outgoing Correspondence	1
02/10/2018	Request For Change	7